AbbVie Inc. Long-term Debt and Lease Obligation, Current
AbbVie Inc. (ABBV) had Long-term Debt and Lease Obligation, Current of $8.34 billion as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Long-Term Debt and Lease Obligation, Current
us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent · last filed 2026-08-03
- 2026-06-30: Long-term Debt and Lease Obligation, Current $8.34B.
- 2026-03-31: Long-term Debt and Lease Obligation, Current $8.33B.
- 2025-12-31: Long-term Debt and Lease Obligation, Current $6.06B.
- 2025-09-30: Long-term Debt and Lease Obligation, Current $1.98B.
| Period end | Long-term Debt and Lease Obligation, Current | Long-term Debt and Lease Obligation, Current as first filed |
|---|---|---|
| 2026-06-30 | $8.34B 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $8.33B 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $6.06B 10-Q · filed 2026-08-03 | |
| 2025-09-30 | $1.98B 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $1.97B 10-Q · filed 2025-08-04 | |
| 2025-03-31 | $3.77B 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $6.80B 10-K · filed 2026-02-20 | |
| 2024-09-30 | $12.57B 10-Q · filed 2024-11-04 | |
| 2024-06-30 | $12.59B 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $10.19B 10-Q · filed 2024-05-03 | |
| 2023-12-31 | $7.19B 10-K · filed 2025-02-14 | |
| 2023-09-30 | $5.11B 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $5.20B 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $2.80B 10-Q · filed 2023-05-05 | |
| 2022-12-31 | $4.13B 10-K · filed 2024-02-20 | |
| 2022-09-30 | $9.20B 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $11.91B 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $9.94B 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $12.48B 10-K · filed 2023-02-17 | |
| 2021-09-30 | $6.66B 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $7.88B 10-Q · filed 2021-08-02 | |
| 2021-03-31 | $11.34B 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $8.47B 10-K · filed 2022-02-18 | |
| 2020-09-30 | $4.72B 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $5.31B 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $3.76B 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $3.75B 10-K · filed 2021-02-19 | |
| 2019-09-30 | $5.28B 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $5.33B 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $1.58B 10-Q · filed 2019-05-03 | |
| 2018-12-31 | $1.61B 10-K · filed 2020-02-21 | |
| 2018-09-30 | $1.02B 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $3.02B 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $6.01B 10-Q · filed 2018-05-04 | |
| 2017-12-31 | $6.01B 10-K · filed 2019-02-27 | |
| 2017-09-30 | $3.02B 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $3.02B 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $25.00M 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $25.00M 10-K · filed 2018-02-16 | |
| 2016-09-30 | $26.00M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $23.00M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $2.02B 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $2.02B 10-K · filed 2017-02-17 | |
| 2015-09-30 | $8.00M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $4.01B 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $4.02B 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $4.01B 10-K · filed 2016-02-19 | $4.02B 10-K · filed 2015-02-20 |
| 2014-09-30 | $22.00M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $20.00M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $18.00M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $18.00M 10-K · filed 2015-02-20 | |
| 2013-09-30 | $23.00M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $22.00M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $22.00M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $22.00M 10-K · filed 2014-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |